What is the Impact Factor of Expert Review of Vaccines?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Expert Review of Vaccines is 5.60, ranking in quartile Q1 of Web of Science (SCIE).

Is Expert Review of Vaccines indexed in Web of Science or Scopus?

Yes, Expert Review of Vaccines is indexed in Web of Science (SCIE, Q1 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.280 (Q1) and an H-index of 117.

Who publishes Expert Review of Vaccines and what is the Article Processing Charge (APC)?

Expert Review of Vaccines is published by Taylor and Francis Ltd.. The estimated Article Processing Charge (APC) is approximately $3,541 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Expert Review of Vaccines?

The official ISO-4 abbreviation of Expert Review of Vaccines is "EXPERT REV VACCINES" with common acronym "ervx". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q1Scopus Q1SCImago #3,237Top JournalReview JournalHybrid

Expert Review of Vaccines

Acronym:ervx

•

Abbreviation (ISO):EXPERT REV VACCINES

•

Identifier (ISSN):1476-0584(Print)/1744-8395(Online)

•

Publisher:Taylor and Francis Ltd.

Official Website Submission Portal Compare

Clarivate IF (2026)

5.6↑ +0.8

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIETop Tier

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Expert Review of Vaccines

WoS Q1

Annual Impact Factor Metric

Current (2026):5.6

Scopus SJR & RankScopus Q1

1.28

#3,237

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

117

117 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier

Self-Citation Rate1.8%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

162articles/year

99.25% Gold OA•46.4% Original Research

Aims & Scope

Expert Review of Vaccines (ISSN 1476-0584) provides expert commentary on the development, application, and clinical effectiveness of new vaccines. Coverage includes vaccine technology, vaccine adjuvants, prophylactic vaccines, therapeutic vaccines, AIDS vaccines and vaccines for defence against bioterrorism. All articles are subject to rigorous peer-review. The vaccine field has been transformed by recent technological advances, but there remain many challenges in the delivery of cost-effective, safe vaccines. Expert Review of Vaccines facilitates decision making to drive forward this exciting field.

Topics Covered (Recognized by AI)

Medicine98.8%Biology93.2%Immunology84.4%Genetics79%Virology76%Pathology66.7%Internal medicine58.9%Immune system57.7%Antigen48.9%Vaccination47.3%Antibody46.4%Chemistry40.1%Biochemistry37.6%Virus27.4%Immunization27.1%Disease23.9%Gene22.3%

Primary Research Areas

Medicine Immunology

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

IMMUNOLOGY

Rank42/183

IndexSCIE

JCISCIE2026

IMMUNOLOGY

Rank75/183

IndexSCIE

Category	Index	Rank	Quartile
IMMUNOLOGY	JCRSCIE	42/183	Q1
IMMUNOLOGY	JCISCIE	75/183	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF5.6

Articles / Year81

Total Citations27

2025

IF4.8

Articles / Year107

Total Citations453

2024

IF5.5

Articles / Year83

Total Citations940

2023

IF6.2

Articles / Year108

Total Citations1,614

2022

IF5.683

Articles / Year137

Total Citations2,578

Year	Impact Factor	Articles / Year	Total Citations
2026	5.6	81	27
2025	4.8	107	453
2024	5.5	83	940
2023	6.2	108	1,614
2022	5.683	137	2,578
2021	5.217	190	5,685
2020	4.362	92	2,962
2019	4.531	93	3,255
2018	4.271	96	4,570
2017	—	99	4,341
2016	—	128	4,986
2015	—	139	5,284

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #3,237Scopus Q1SCImago Profile

Scopus Coverage:2002-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q1

1.28

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

5.48

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,541 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,725

3-Year Documents368

Citable Documents319

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)3

Citations in government and international policy documents

Female Author Rate50.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Drug DiscoveryQ1

PharmacologyQ1

ImmunologyQ2

Molecular MedicineQ2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 1.8%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

2区 (Zone 2)Medicine

Minor Category (Specific Field):

3区IMMUNOLOGY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Expert Review of Vaccines (acronym: ervx, abbr: EXPERT REV VACCINES, ISSN: 1476-0584) is a peer-reviewed international scholarly journal in the field of Medicine, published by Taylor and Francis Ltd. in England since 2002. The periodical holds a Journal Impact Factor (JIF) of 5.60, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.280 (Q1), an H-index of 117.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 162 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,541 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.